Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Impaired rRNA Synthesis Contributes to BCL-2 Induced Chemoresistance in Diffuse Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 1620.

https://doi.org/10.1182/blood-2024-207210

Published: 2024

Journal Articles

Results of an Italian Retrospective Clinical Experience on Mediastinal Gray Zone Lymphoma

Blood (2023) 142 (Supplement 1): 4503.

https://doi.org/10.1182/blood-2023-180036

Published: 2023

Journal Articles

A Digital Gene-Expression Signature Supports Mediastinal Gray Zone Lymphoma Stratification within Classical Hodgkin or Primary Mediastinal B-Cell Lymphoma

Maria Carmela Vegliante, Grazia Gargano, Flavia Esposito, Giuseppina Opinto, Gian Maria Zaccaria, Susanna Anita Pappagallo, Paolo Mondelli, Giacomo Loseto, Anna Scattone, Elena Sabattini, Claudio Agostinelli, Valentina Tabanelli, Luca Nassi, Attilio Guarini, Stefano A Pileri, Sabino Ciavarella

Blood (2022) 140 (Supplement 1): 9312–9313.

https://doi.org/10.1182/blood-2022-159478

Published: 2022

Journal Articles

Dysregulation of PRMT5 in Chronic Lymphocytic Leukemia Supports Transformation to Diffuse Large B-Cell Lymphoma

Blood (2022) 140 (Supplement 1): 8746–8747.

https://doi.org/10.1182/blood-2022-169949

Published: 2022

Journal Articles

Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry

Blood (2019) 134 (24): 2159–2170.

https://doi.org/10.1182/blood.2019000779

Published: 2019

Includes: Supplemental data

Journal Articles

Integration of Nanostring Profiling and Functional Characterization of Oxidative and Replicative Stress Biomarkers Identifies Poor Prognosis MYC/BCL-2 Positive Diffuse Large B-Cell Lymphoma Subsets, Providing Opportunities for Precision Therapies

Enrico Derenzini, MD PhD, Alessandra Rossi, PhD, Claudio Agostinelli, MD, Maura Rossi, PhD, Federica Melle, PhD, Giovanna Motta, PhD, Marco Fabbri, PhD, Tommaso Radice, MD, Safaa Ramadan, PhD MD, Anna Vanazzi, MD, Valentina Tabanelli, MD, Stefano Fiori, MD, Annalisa Chiappella, MD, Alberto Agazzi, MD, Pier Luigi Zinzani, MD, Umberto Vitolo, Corrado Tarella, MD Prof, Stefano A. Pileri, MD PhD

Blood (2018) 132 (Supplement 1): 676.

https://doi.org/10.1182/blood-2018-99-118329

Published: 2018

Journal Articles

ABC Subtype, TP53 Mutation and BCL2 Overexpression are Associated with a Worse Outcome in Untreated Poor-Risk Young Diffuse Large B-Cell Lymphoma: Results from the Frontline Phase III BIO-DLBCL04 Study of the Fondazione Italiana Linfomi

Blood (2017) 130 (Supplement 1): 4010.

https://doi.org/10.1182/blood.V130.Suppl_1.4010.4010

Published: 2017

Journal Articles

The Prognostic Role of Cell of Origin Profile and Myc Expression Assessed By Immunohistochemistry in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of First-Line Randomized BIO-DLCL04 Trial of Fondazione Italiana Linfomi (FIL)

Annalisa Chiappella, Claudio Agostinelli, Maurizio Martelli, Simona Righi, Andrea Evangelista, Emanuele Angelucci, Monica Balzarotti, Angelo Michele Carella, Manuel Gotti, Domenico Novero, MD, Giuseppe Rossi, MD, Caterina Stelitano, Marco Ladetto, Gianluca Gaidano, Stefano A Pileri, Umberto Vitolo

Blood (2015) 126 (23): 5041.

https://doi.org/10.1182/blood.V126.23.5041.5041

Published: 2015

Journal Articles

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation

Blood (2015) 125 (16): 2530–2543.

https://doi.org/10.1182/blood-2014-12-619783

Published: 2015

Includes: Supplemental data

Journal Articles

Genomic Instability and Activation Of The DNA Damage Response Pathway Is An Independent Predictor Of Poor Prognosis, Is Associated With MYC Expression and Is a Promising Target For Therapy In Diffuse Large B Cell Lymphoma

Enrico Derenzini, MD, Claudio Agostinelli, MD, Ilaria Iacobucci, PhD, Enrica Imbrogno, Beatrice Casadei, MD, Giovanni Martinelli, MD, Stefano A Pileri, MD, Pier Luigi Zinzani, MD

Blood (2013) 122 (21): 3015.

https://doi.org/10.1182/blood.V122.21.3015.3015

Published: 2013

Journal Articles

Identification of Differentially Expressed miRNAs in Peripheral t-Cell Lymphomas

Pier Paolo Piccaluga, Sr., MD, PhD, Maria Antonella Laginestra, BS, Maura Rossi, PhD, Antonio De Leo, MD, Davide Gibellini, MD, Anna Gazzola, maria Rosaria Sapienza, PhD, Claudio Agostinelli, M.D., Ph.D., Stefano Pileri, MD

Blood (2011) 118 (21): 773.

https://doi.org/10.1182/blood.V118.21.773.773

Published: 2011

Journal Articles

Developing a Novel Class of Drug to Inhibit Protein Arginine Methyltransferase 5 (PRMT5) Enzyme Dysregulation in Mantle Cell Lymphoma

Fengting Yan, M.D., Ph.D., Porsha Smith, Lapo Alinari, MD., Ph.D., John Ryu, Bo Yu, Ph.D., Vrajesh Karkhanis, Ph.D., Sookil Tae, Ph.D., John T. Patton, Emily E. Wilding, Kate Gordon, Kiran Mahasenan, Ph.D., Deepak Bhasin, Ph.D., Claudio Agostinelli, M.D., Ph.D., Stefano A. Pileri, M.D., John C. Byrd, MD, Said Sif, Ph.D., Pui-kai Li, Ph.D., Chenglong Li, Ph.D., Robert A. Baiocchi, M.D., Ph.D.

Blood (2011) 118 (21): 595.

https://doi.org/10.1182/blood.V118.21.595.595

Published: 2011

Journal Articles

Alteration of BIRC3 and Multiple Other NF-κB Pathway Genes in Splenic Marginal Zone Lymphoma

Blood (2011) 118 (21): 264.

https://doi.org/10.1182/blood.V118.21.264.264

Published: 2011

Journal Articles

Molecular Diagnosis of Peripheral T-Cell Lymphoma/NOS From Formalin Fixed Paraffin Embedded Tissues,

Pier Paolo Piccaluga, Sr., MD, PhD, Antonio De Leo, MD, Maura Rossi, PhD, Maria Antonella Laginestra, BS, maria Rosaria Sapienza, PhD, Anna Gazzola, Claudia Mannu, BS, Claudio Agostinelli, M.D., Ph.D., Francesco Bacci, MD, Elena Sabattini, MD, Sylvia Hartmann, MD, Martin Leo Hansmann, MD, Stefano A Pileri

Blood (2011) 118 (21): 3662.

https://doi.org/10.1182/blood.V118.21.3662.3662

Published: 2011

Journal Articles

Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma

Blood (2011) 118 (18): 4930–4934.

https://doi.org/10.1182/blood-2011-06-359166

Published: 2011

Includes: Supplemental data

Journal Articles

Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes

Blood (2011) 117 (13): 3596–3608.

https://doi.org/10.1182/blood-2010-08-301556

Published: 2011

Includes: Supplemental data

Journal Articles

Early Interim 18 f-FDG PET In Hodgkin's Lymphoma: Evaluation on 304 Patients

Blood (2010) 116 (21): 3879.

https://doi.org/10.1182/blood.V116.21.3879.3879

Published: 2010

Journal Articles

Gene Expression Analysis Uncovers Similarity and Differences Among Burkitt Lymphoma Subtypes

Blood (2010) 116 (21): 2494.

https://doi.org/10.1182/blood.V116.21.2494.2494

Published: 2010

Journal Articles

Detection of LMO2 in Normal Human Tissues and Haematopoietic and Non-Haematopoietic Tumours by a Newly Developed Rabbit Monoclonal Antibody.

Claudio Agostinelli, Jennifer C Paterson, Rajeev Gupta, Simona Righi, Federica Sandri, Pier Paolo Piccaluga, Francesco Bacci, Elena Sabattini, Stefano A. Pileri, MD, Teresa Marafioti, MD

Blood (2009) 114 (22): 2942.

https://doi.org/10.1182/blood.V114.22.2942.2942

Published: 2009

Journal Articles

PDGFRA Activity Is Mediated by An Autocrine Loop in Peripheral T-Cell Lymphoma/Not Otherwise Specified (PTCL/NOS).

Maura Rossi, Francesco Alviano, Antonella Laginestra, Pierluigi Tazzari, MD, Francesca Ricci, BS, Aurora Esposito, Claudio Agostinelli, Maria Teresa Sista, Anna Gazzola, Claudia Mannu, Simona Righi, Maria Rosaria Sapienza, Gian Paolo Bagnara, Sylvia Hartmann, Martin Leo Hansmann, Pier Luigi Zinzani, Stefano Aldo Pileri, Pier Paolo Piccaluga

Blood (2009) 114 (22): 4631.

https://doi.org/10.1182/blood.V114.22.4631.4631

Published: 2009

NARROW

Impaired rRNA Synthesis Contributes to BCL-2 Induced Chemoresistance in Diffuse Large B-Cell Lymphoma

Results of an Italian Retrospective Clinical Experience on Mediastinal Gray Zone Lymphoma

A Digital Gene-Expression Signature Supports Mediastinal Gray Zone Lymphoma Stratification within Classical Hodgkin or Primary Mediastinal B-Cell Lymphoma

Dysregulation of PRMT5 in Chronic Lymphocytic Leukemia Supports Transformation to Diffuse Large B-Cell Lymphoma

Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry

Integration of Nanostring Profiling and Functional Characterization of Oxidative and Replicative Stress Biomarkers Identifies Poor Prognosis MYC/BCL-2 Positive Diffuse Large B-Cell Lymphoma Subsets, Providing Opportunities for Precision Therapies

ABC Subtype, TP53 Mutation and BCL2 Overexpression are Associated with a Worse Outcome in Untreated Poor-Risk Young Diffuse Large B-Cell Lymphoma: Results from the Frontline Phase III BIO-DLBCL04 Study of the Fondazione Italiana Linfomi

The Prognostic Role of Cell of Origin Profile and Myc Expression Assessed By Immunohistochemistry in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of First-Line Randomized BIO-DLCL04 Trial of Fondazione Italiana Linfomi (FIL)

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation

Genomic Instability and Activation Of The DNA Damage Response Pathway Is An Independent Predictor Of Poor Prognosis, Is Associated With MYC Expression and Is a Promising Target For Therapy In Diffuse Large B Cell Lymphoma

Identification of Differentially Expressed miRNAs in Peripheral t-Cell Lymphomas

Developing a Novel Class of Drug to Inhibit Protein Arginine Methyltransferase 5 (PRMT5) Enzyme Dysregulation in Mantle Cell Lymphoma

Alteration of BIRC3 and Multiple Other NF-κB Pathway Genes in Splenic Marginal Zone Lymphoma

Molecular Diagnosis of Peripheral T-Cell Lymphoma/NOS From Formalin Fixed Paraffin Embedded Tissues,

Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma

Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes

Early Interim 18 f-FDG PET In Hodgkin's Lymphoma: Evaluation on 304 Patients

Gene Expression Analysis Uncovers Similarity and Differences Among Burkitt Lymphoma Subtypes

Detection of LMO2 in Normal Human Tissues and Haematopoietic and Non-Haematopoietic Tumours by a Newly Developed Rabbit Monoclonal Antibody.

PDGFRA Activity Is Mediated by An Autocrine Loop in Peripheral T-Cell Lymphoma/Not Otherwise Specified (PTCL/NOS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only